Stock overview
Keros Therapeutics Inc.
Explore the company, reported ownership, price history, and available source evidence.
KEROS THERAPEUTICS INC (KROS) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $11.62
- · KROS
- Tracked holders
- 1 fund
- Latest available 13F per fund
KROS · USD
Price
$11.62
-$4.18
(-26.46%)
over selected range
Close · Sep 25, 2026
Market closed
252 stored daily closes
$11.62
Sep 25, 2026
- Range low
- $9.91
- Range high
- $21.84
- Observations
- 252
- Session date
- Sep 25, 2026
Sep 25, 2025–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Renaissance Technologies largest tracked holder Q2 2026 · filed Aug 13, 2026 · SEC filing | −21% 26'Q2 | $3,842,220 | 0.01% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market